Yubo International Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was USD 0.15388 million compared to USD 0.023183 million a year ago. Net loss was USD 0.683994 million compared to USD 1.07 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.